EMA announces the pilot procedure for clinical trial application consultation under the ACT EU initiative becomes permanent from January 2027.
Lithuania VVKT · LithuaniaLithuania introduces a new state fee for pharmaceutical product re-registration, effective 3 October 2026, under Government Resolution No. 1458.
Lithuania VVKT · LithuaniaA new state fee for issuing and amending parallel import licences for medicinal products entered into force on 3 October 2026.
Lithuania VVKT · LithuaniaReminder of requirements for providing public information about prescription medicines and organizing professional events in Lithuania.
Lithuania VVKT · LithuaniaLithuania's health technology assessment body reports receipt and review of 6 new applications and continuation of 4 existing applications in October.
Lithuania VVKT · LithuaniaAn intensive week-long mission in Vilnius was held to build Ukraine's capacity in clinical trial evaluation as part of an EU twinning programme.
Lithuania VVKT · LithuaniaTechnical disruptions affecting connections to EU regulatory information systems (CTS, EURS, Eudamed and others) reported from 27 August 2026.
Lithuania VVKT · LithuaniaLithuania inaugurated the first cell therapy and personalized medicine centre in the Baltic region in Vilnius, producing next-generation cell therapies and personalized therapeutic vaccines.
Lithuania VVKT · LithuaniaHeads of European medicines and HTA agencies met in Ireland during the EU Council presidency to discuss cooperation on medicines access.
Lithuania VVKT · Lithuania2026 metų rugsėjo 15–16 dienomis Vilniuje vyko tarptautinė konferencija (ISPE Nordic-Baltic Validation Summit), skirta kvalifikavimo ir validavimo aktualijoms. Joje dalyvavo farmacijos srities specialistai iš Lietuvos...
Lithuania VVKT · LithuaniaRugsėjo 23 d. Ekstremalių sveikatai situacijų centro (ESSC) ir Valstybinės vaistų kontrolės tarnybos (VVKT) atstovai susitiko aptarti ES bendrai finansuojamo CHESSMEN projekto rezultatų ir jų pritaikymo Lietuvoje. CHE...
Lithuania VVKT · LithuaniaValstybinė vaistų kontrolės tarnyba (toliau - VVKT), vadovaudamasi teisės aktuose numatyta tvarka, gauna informaciją iš farmacinių kompanijų apie perleistas vertes juridiniams asmenims, taip pat informaciją iš Valstyb...
Lithuania VVKT · LithuaniaState fees for pharmaceutical activity licensing changed from 3 October 2026; payment code 5748 applies.
Lithuania VVKT · LithuaniaRugsėjo mėnesį Strasbūre (Prancūzijoje) vyko Europos vaistų kokybės ir sveikatos priežiūros direktorato (EDQM) Ekspertų komiteto medicinos produktų klastojimo ir susijusių nusikaltimų keliamoms visuomenės sveikatos ri...
Lithuania VVKT · LithuaniaSavaitgalį Lietuvos sveikatos mokslų universiteto Farmacijos fakultete Kaune vyko Lietuvos farmacijos sąjungos (LFS) 41-asis suvažiavimas ir tarptautinė mokslinė - praktinė konferencija „Farmacija: nuo vaisto signatūr...
Lithuania VVKT · LithuaniaLithuanian medicines authority published a list of authorised medicines whose holders failed to report first market entry within six months of registration.
Lithuania VVKT · LithuaniaVVKT published an updated list of reimbursed medicines with minimal co-payment experiencing temporary supply disruption in the Lithuanian market.
Lithuania VVKT · LithuaniaVaistininko darbas – tai ne tik žinios ir profesionalumas. Tai gebėjimas išklausyti, kantriai paaiškinti, nuraminti, padrąsinti ir kasdien prisidėti prie žmogaus gerovės. Tai profesija, kurioje žmogiškumas ir rūpestis...
Lithuania VVKT · LithuaniaVVKT published updated data on reimbursed medicines with minimal co-payment experiencing temporary supply disruption in the Lithuanian market as of 2 September 2026.
Lithuania VVKT · LithuaniaLithuania VVKT announces transition to scheduled submission of pharmaceutical reimbursement applications after 8 months of uneven application flow.
Lithuania VVKT · LithuaniaŠią vasarą Valstybinėje vaistų kontrolės tarnyboje (VVKT) praktiką atliko Inesa ir Žygimantas. Praktikos metu studentai turėjo galimybę ne tik susipažinti su kasdiene Tarnybos veikla, bet ir iš arčiau pamatyti, kaip …
Lithuania VVKT · LithuaniaInformacija pateikiama šiomis kalbomis: 🇱🇹 🇪🇺 🇺🇦 / Information is available in the following languages: 🇱🇹 🇪🇺 🇺🇦 / Інформація доступна такими мовами: 🇱🇹 🇪🇺 🇺🇦 Valstybinė vaistų kontrolės tarnyba (VVKT) kartu su partne...
Lithuania VVKT · LithuaniaFrom 15 September, VVKT publishes information on applications to register parallel-imported medicinal products in interactive Power BI format.
Lithuania VVKT · LithuaniaVVKT published updated data on reimbursed medicines with minimum co-payment experiencing temporary supply disruption in the Lithuanian market as of 7 October 2026.
Lithuania VVKT · LithuaniaValstybinė vaistų kontrolės tarnyba, vadovaudamasi teisės aktuose numatyta tvarka, kasmet gauna farmacinių kompanijų teikiamą informaciją apie perleistas vertes specialistams. Pateikiame apibendrintus duomenis apie pe...
Lithuania VVKT · LithuaniaInformacija pateikiama šiomis kalbomis: 🇱🇹 🇪🇺 🇺🇦 / Information is available in the following languages: 🇱🇹 🇪🇺 🇺🇦 / Інформація доступна такими мовами: 🇱🇹 🇪🇺 🇺🇦 Rugpjūčio 24–28 dienomis Vilniuje vyko intensyvi penkių di...
Lithuania VVKT · LithuaniaVVKT published updated data on reimbursed medicines with minimal co-payment experiencing temporary supply disruption in the Lithuanian market as of 26 August 2026.
Lithuania VVKT · LithuaniaLithuania's State Medicines Control Service revokes the validity of registration certificates for specified medicinal products effective 30 September 2026.
Lithuania VVKT · LithuaniaVVKT published updated data on reimbursed medicines with minimum co-payment experiencing temporary supply disruption in the Lithuanian market as of 14 October 2026.
Lithuania VVKT · LithuaniaSupply of Binocrit (epoetin alfa) and Zarzio (filgrastim) injectable solutions has resumed.
Lithuania VVKT · LithuaniaSupply of Amphotericin B liposomal Tillomed 50 mg powder for infusion concentrate has resumed on the Lithuanian market.
Lithuania VVKT · LithuaniaUpdated list of reimbursed medicines with minimum co-payment experiencing temporary supply disruption in the Lithuanian market.
Lithuania VVKT · LithuaniaSupply of four named medicinal products (Ziextenzo, Betaferon, Aspirin Cardio, Ultravist) has resumed.
Lithuania VVKT · LithuaniaLithuania's State Medicines Control Service revokes the validity of pharmaceutical preparation registration certificates by order dated 31 August 2026.
Lithuania VVKT · LithuaniaLithuania's State Medicines Control Service revokes marketing authorisation certificates for specified medicinal preparations effective 29 July 2026.
Lithuania VVKT · LithuaniaTemporary supply disruption of specified medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaSupply of Druniler (febuxostat) 80 mg tablets and Zinnat (cefuroxime) 125 mg/5 ml granules resumed to the Lithuanian market.
Lithuania VVKT · LithuaniaTemporary supply disruption of specified medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaTemporary supply disruption of specified medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaSupply of Tarka 180 mg/2 mg modified-release tablets has resumed on the Lithuanian market.
Lithuania VVKT · LithuaniaTemporary supply disruption of specified medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaTemporary supply disruption of specified medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaSupply of Gepretix (progesterone) 200 mg soft capsules and Encepur children (tick-borne encephalitis virus vaccine) has resumed.
Lithuania VVKT · LithuaniaTemporary supply disruption of specified medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaTemporary supply disruption of specified medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaSupply of Finasteride Teva 5 mg film-coated tablets N30 to the Lithuanian market has resumed.
Lithuania VVKT · LithuaniaTemporary supply disruption of specified medicinal products in the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaTemporary supply disruption of certain medicinal products to the Lithuanian market; planned resumption dates listed.
Lithuania VVKT · LithuaniaVVKT published updated data on reimbursed medicines with minimum co-payment experiencing temporary supply disruption in the Lithuanian market as of 23 September 2026.
Lithuania VVKT · Lithuania